LabAutomation 2006 - SLAS
LabAutomation 2006 - SLAS LabAutomation 2006 - SLAS
TP25 Joseph Kofman Pfizer San Diego, California joseph.kofman@pfizer.com LabAutomation2006 Co-Author Todd Baumgartner Embracing the Unattainable: Creating an Integrated Electronic Environment for Analytical Laboratories Even a superficial review of working practices within analytical laboratories across the pharmaceutical industry reveals key areas within the workflow that have unmet needs with respect to integrated informatics systems. Despite tremendous efforts to move towards a “paperless” environment, current systems within analytical laboratories typically provide autonomous support in relation to other analytical processes. Knowledge is successfully captured and accumulated, but not shared effectively. The development and implementation of a complete “chain of custody” solution for laboratory data and information is needed to fully meet the compliance requirements of 21 CFR Part 11, provide extended productivity improvements, and reduce the support and maintenance costs of multiple redundant systems. There has been work in integrating different solutions (e.g. CDS and LIMS); however the strategy for a complete system has not been defined. A critical aspect of the Analytical Laboratory Integrated Solution (ALIS) is that each of the systems is linked through touch points (common interfaces), and all laboratory data is acquired and stored electronically by specialty applications, but is accessible for data mining through all associated applications. A prototype of ALIS was built based on a strategic process map and focused on integration and information exchange between independent applications. The integrated solution was designed so that information flow within the analytical laboratory was improved or at least maintained. The benefits gained from this integrated system are far greater than if the components were implemented independently. TP26 Saikalyan Kotha Flow Sciences Leland, North Carolina skotha@flowsciences.com Co-Author(s) Ray Ryan Douglas B. Walters, KCP Inc. Ventilated Robotic Enclosures for Product and Personal Protection in High-Throughput Laboratories Today’s potent material handling laboratories have changed significantly. Synthesis-based R&D has moved into the new millennium and been supplemented with processes using sophisticated computer and high throughput robotic technology. The laboratory use of novel compounds of unknown potency is rapidly expanding, and requires flexible task-specific containment solutions to minimize environmental impact, protect operators, and optimize process efficiency. While many laboratory operations can only be safely performed in large traditional chemical hoods, or biological safety cabinets limitations often arise because containment is not always effective, the hood design is not task-specific and is not designed for high through put equipment, relocation is difficult, and purchase, installation and operation is expensive. Hence, in many cases unique process-specific containment solutions must be developed to provide safe, adaptable and energy efficient enclosures in the rapidly changing laboratory environment. This presentation describes several custom designed vented enclosures developed for pharmaceutical and medical research. This project encompassed three distinct phases critical to the project’s successful completion. The definition of specific robotic equipment such as, liquid handling, incubators, and powder handling equipment. Optimizing designs with computational fluid dynamics (CFD) to maximize containment and energy efficiency, and to resolve ergonomic issues and provide easy operator access to the enclosed equipment. Commissioning of enclosures with on-site testing to ensure effective containment. This project emphasizes the importance of task-specific containment solutions for use with high-through put and robotic equipment 164
TP27 Steve Lappin Amgen Thousand Oaks, California slappin@amgen.com Where Laboratory Technologies Emerge and Merge Co-Author Alex Mladenovic, Amgen Inc. A Simple and Compact Liquid Handler/Centrifuge Integration Many biological assays and sample preparation protocols require separation of solids from liquid for processing, often accomplished by centrifugation. As centrifuge integrations into automated platforms are typically large and complex and require another component to shuttle plates, they are often not appropriate for smaller labs or lower throughput applications and can be prohibitively expensive. We have developed and implemented compact platform consisting of an integrated Velocity11 Vspin centrifuge (and Access unit) with a Beckman Biomek NX that requires no additional components to load the centrifuge. We have written a rudimentary driver to control the centrifuge directly from the Biomek software and is applicable to all Biomek software versions. The entire device measures only 0.9M x 1.3M and is appropriate for many applications that require washes and spins, such as flow cytometry sample preparation, blood preparations and antibody labeling experiments. TP28 Brad Larson Promega Corporation Madison, Wisconsin brad.larson@promega.com Co-Author(s) Tracy Worzella Promega Corporation Siegfried Sasshofer Tecan Aoife Gallagher Deerac Fluidics Automated Multiplexed Cell-Based Assays for High-Throughput Drug Discovery Today’s high-throughput screening facilities face increasing demands to generate more information from existing compound libraries. An appealing solution is to perform multiplexed assays during the same cell-based screen. A multiplexed-assay approach allows for the evaluation of multiple parameters from the same sample source. An overall decrease in screening costs and variability are also realized when different assays can be used on the same plate of cells. Here we provide proof-of-principle data by combining Promega’s cell-based screening assays in a multiplexed format with a variety of high-throughput instrumentation. Live cell reporter, cell viability, and caspase – 3/7 activity assays were combined in 96, 384, and 1536-well formats. A unique combination and detection of both luminescent and fluorescent chemistries within the same well is also demonstrated. The single-reagent additions to each well, extended signal half-lives and sensitivity of each of these compatible chemistry combinations make them ideal for high-throughput liquid handling and detection. 165
- Page 116 and 117: MP23 Robin Clark deCODE Biostructur
- Page 118 and 119: MP27 J. Colin Cox Duke University M
- Page 120 and 121: MP31 Frank Doffing IMM - Institut f
- Page 122 and 123: MP35 Aoife Gallagher Deerac Fluidic
- Page 124 and 125: MP39 Yunseok Heo University of Mich
- Page 126 and 127: MP43 David Humphries Lawrence Berke
- Page 128 and 129: MP47 Joohoon Kim University of Texa
- Page 130 and 131: MP51 Michelle Li Saint Louis Univer
- Page 132 and 133: MP55 Philip Manning Procter & Gambl
- Page 134 and 135: MP59 Irena Nikcevic University of C
- Page 136 and 137: MP63 Qiaosheng Pu Virginia Commonwe
- Page 138 and 139: MP67 Alexander Roth National Instit
- Page 140 and 141: MP71 Sang Jun Son University of Mar
- Page 142 and 143: MP75 Lois Tack PerkinElmer Life & A
- Page 144 and 145: MP79 Angelo Trivelli J Craig Venter
- Page 146 and 147: MP83 Tracy Worzella Promega Corpora
- Page 148 and 149: MP87 Peter Greenhalgh Astech Projec
- Page 150 and 151: MP91 David Ferrick Seahorse Bioscie
- Page 152 and 153: MP95 Christine Brideau Merck Frosst
- Page 154 and 155: TP01 Marc Pfeifer Roche Molecular S
- Page 156 and 157: TP05 Marcy Engelstein Millipore Cor
- Page 158 and 159: TP09 Aoife Gallagher Deerac Fluidic
- Page 160 and 161: TP13 Ulrike Honisch Greiner Bio-One
- Page 162 and 163: TP17 Michael Gary Jackson Beckman-C
- Page 164 and 165: TP21 Libby Kellard Millipore Danver
- Page 168 and 169: TP29 Hanh Le PerkinElmer Life and A
- Page 170 and 171: TP33 Stephen Lowry Thermo Electron
- Page 172 and 173: TP37 Donald J. Nagy California Comp
- Page 174 and 175: TP41 Clifford Olson Zinsser Analyti
- Page 176 and 177: TP45 Nick Price Invitrogen Corporat
- Page 178 and 179: TP49 Michael Raimo Arqule Inc. Wobu
- Page 180 and 181: TP53 Jim Schools Biosero, Inc Monro
- Page 182 and 183: TP57 Darcy Shave Waters Corporation
- Page 184 and 185: TP61 Robert Stanaker Perkin Elmer D
- Page 186 and 187: TP65 Henrik Svennberg Astrazeneca R
- Page 188 and 189: TP69 Paige Vinson Thermo Electron C
- Page 190 and 191: TP73 Thomas Weierstall Qiagen Gmbh
- Page 192 and 193: TP77 Susan Yan Pierce Biotechnology
- Page 194 and 195: TP81 Wayne Bowen TTP LabTech Melbou
- Page 196 and 197: TP85 Evan F. Cromwell Blueshift Bio
- Page 198 and 199: TP89 Wanli Xing Tsinghua University
- Page 200 and 201: TP93 Holger Gumm Sepiatec GmbH Berl
- Page 202 and 203: Notes LabAutomation2006 200
- Page 204 and 205: LabAutomation2006 Monday, January 2
- Page 206 and 207: LabAutomation2006 Monday, January 2
- Page 208 and 209: LabAutomation2006 Tuesday, January
- Page 210 and 211: LabAutomation2006 Tuesday, January
- Page 212 and 213: Notes LabAutomation2006 210
- Page 214 and 215: LabAutomation2006 New Product Launc
TP27<br />
Steve Lappin<br />
Amgen<br />
Thousand Oaks, California<br />
slappin@amgen.com<br />
Where Laboratory Technologies Emerge and Merge<br />
Co-Author<br />
Alex Mladenovic, Amgen Inc.<br />
A Simple and Compact Liquid Handler/Centrifuge Integration<br />
Many biological assays and sample preparation protocols require separation of solids from liquid for processing, often accomplished by<br />
centrifugation. As centrifuge integrations into automated platforms are typically large and complex and require another component to<br />
shuttle plates, they are often not appropriate for smaller labs or lower throughput applications and can be prohibitively expensive. We have<br />
developed and implemented compact platform consisting of an integrated Velocity11 Vspin centrifuge (and Access unit) with a Beckman<br />
Biomek NX that requires no additional components to load the centrifuge. We have written a rudimentary driver to control the centrifuge<br />
directly from the Biomek software and is applicable to all Biomek software versions. The entire device measures only 0.9M x 1.3M and<br />
is appropriate for many applications that require washes and spins, such as flow cytometry sample preparation, blood preparations and<br />
antibody labeling experiments.<br />
TP28<br />
Brad Larson<br />
Promega Corporation<br />
Madison, Wisconsin<br />
brad.larson@promega.com<br />
Co-Author(s)<br />
Tracy Worzella<br />
Promega Corporation<br />
Siegfried Sasshofer<br />
Tecan<br />
Aoife Gallagher<br />
Deerac Fluidics<br />
Automated Multiplexed Cell-Based Assays for High-Throughput Drug Discovery<br />
Today’s high-throughput screening facilities face increasing demands to generate more information from existing compound libraries.<br />
An appealing solution is to perform multiplexed assays during the same cell-based screen. A multiplexed-assay approach allows for the<br />
evaluation of multiple parameters from the same sample source. An overall decrease in screening costs and variability are also realized<br />
when different assays can be used on the same plate of cells. Here we provide proof-of-principle data by combining Promega’s cell-based<br />
screening assays in a multiplexed format with a variety of high-throughput instrumentation. Live cell reporter, cell viability, and caspase<br />
– 3/7 activity assays were combined in 96, 384, and 1536-well formats. A unique combination and detection of both luminescent and<br />
fluorescent chemistries within the same well is also demonstrated. The single-reagent additions to each well, extended signal half-lives and<br />
sensitivity of each of these compatible chemistry combinations make them ideal for high-throughput liquid handling and detection.<br />
165